These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 18202791

  • 1. Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma.
    Ko SH, Choi GJ, Lee JH, Han YA, Lim SJ, Kim SH.
    Oncol Rep; 2008 Feb; 19(2):425-33. PubMed ID: 18202791
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells.
    Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S.
    FEBS Lett; 2002 Nov 06; 531(2):278-84. PubMed ID: 12417326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
    Ohtsu N, Takaoka K, Segawa E, Hashitani S, Noguchi K, Kishimoto H, Urade M.
    Oncol Rep; 2010 Jul 06; 24(1):31-6. PubMed ID: 20514441
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression.
    Leem DH, Choi KH, Han HS, Kim JH, Shin JA, Choi ES, Shim JH, Kong G, Min YK, Nam JS, Oh SH, Kim KA, Kwon KH, Cho NP, Cho SD.
    Eur J Cancer Prev; 2010 Jan 06; 19(1):23-30. PubMed ID: 19910795
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
    Zrieki A, Farinotti R, Buyse M.
    Pharm Res; 2008 Sep 06; 25(9):1991-2001. PubMed ID: 18581209
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH, Wan JY, Gong X, Li HZ, Cheng Y.
    Oncol Rep; 2012 Nov 06; 28(5):1681-6. PubMed ID: 22941407
    [Abstract] [Full Text] [Related]

  • 16. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S, Hoti SL, Nazeer Y, Hegde HV.
    Oncotarget; 2016 Jul 05; 7(27):42353-42373. PubMed ID: 27304668
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
    Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, Hart IR, Thomas GJ.
    Cancer Res; 2006 Nov 15; 66(22):10833-42. PubMed ID: 17108119
    [Abstract] [Full Text] [Related]

  • 18. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J, Lee IL, Jendiroba D, Fischer SM, Grossman HB, Sabichi AL.
    Oncol Rep; 2006 Feb 15; 15(2):471-7. PubMed ID: 16391871
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS, Lopez M, Carey RI, Lokeshwar BL.
    Int J Cancer; 2005 Jun 20; 115(3):484-92. PubMed ID: 15688368
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM, O'Sullivan-Coyne G, O'Donovan TR, McKenna SL, O'Sullivan GC.
    Cancer Lett; 2007 Oct 28; 256(2):246-58. PubMed ID: 17707579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.